OLMA · Olema Pharmaceuticals, Inc.
$11.59
+0.24 (+2.11%)
At close · Jul 21
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have incurred net losses since inception, and we expect to continue to incur net losses for the foreseeable future. In addition, we may be unable to continue as a going concern over the long term.”View the 10-Q filed May 12, 2026
Market Cap
$1.01B
Shares
87.35M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
75/100
Short interest 16.1% of shares — P96
Days to cover 5.7 — P85
Price vs VWAP -4.0% — P41
Short-volume trend +23.3% — P96
Short interest change +9.3% — P66
Worst FTD 0.00% of shares — P17
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 14,033,964 | 12,843,113 | +1,190,851 | 5.68 |
| 2026-06-15 | 12,843,113 | 11,927,602 | +915,511 | 7.88 |
| 2026-05-29 | 11,927,602 | 11,587,581 | +340,021 | 10.53 |
| 2026-05-15 | 11,587,581 | 13,041,205 | -1,453,624 | 10.24 |
| 2026-04-30 | 13,041,205 | 12,934,118 | +107,087 | 16.48 |
| 2026-04-15 | 12,934,118 | 12,265,390 | +668,728 | 14.57 |
| 2026-03-31 | 12,265,390 | 8,240,774 | +4,024,616 | 6.30 |
| 2026-03-13 | 8,240,774 | 8,257,215 | -16,441 | 2.96 |
| 2026-02-27 | 8,257,215 | 9,002,172 | -744,957 | 7.48 |
| 2026-02-13 | 9,002,172 | 10,111,842 | -1,109,670 | 5.71 |
| 2026-01-30 | 10,111,842 | 9,100,561 | +1,011,281 | 10.99 |
| 2026-01-15 | 9,100,561 | 10,399,087 | -1,298,526 | 6.27 |
| 2025-12-31 | 10,399,087 | 11,090,858 | -691,771 | 5.19 |
| 2025-12-15 | 11,090,858 | 10,810,748 | +280,110 | 3.48 |
| 2025-11-28 | 10,810,748 | 9,364,250 | +1,446,498 | 1.00 |
| 2025-11-14 | 9,364,250 | 8,366,665 | +997,585 | 9.95 |
| 2025-10-31 | 8,366,665 | 7,545,885 | +820,780 | 5.14 |
| 2025-10-15 | 7,545,885 | 7,791,509 | -245,624 | 6.30 |
| 2025-09-30 | 7,791,509 | 8,239,433 | -447,924 | 6.88 |
| 2025-09-15 | 8,239,433 | 8,413,141 | -173,708 | 4.70 |
| 2025-08-29 | 8,413,141 | 8,481,885 | -68,744 | 26.42 |
| 2025-08-15 | 8,481,885 | 7,636,164 | +845,721 | 14.44 |
| 2025-07-31 | 7,636,164 | 7,638,452 | -2,288 | 17.62 |
Showing 1–23 of 23 settlements
Key facts
CIK
1750284
CUSIP
68062P106
13F (30d)
13 filings
13 filers
Visit website
Investor relations